New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer Read more about New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting Read more about Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China Read more about Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer Read more about Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer
Four Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California Read more about Four Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
Amgen Announces Webcast of 2013 First Quarter Financial Results Read more about Amgen Announces Webcast of 2013 First Quarter Financial Results
Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma Read more about Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma
Amgen Announces 2013 Second Quarter Dividend Read more about Amgen Announces 2013 Second Quarter Dividend
Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference Read more about Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference
Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients Read more about Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients
